Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical

C. Orasch, D. Averbuch, M. Mikulska, C. Cordonnier, D. M. Livermore, I. C. Gyssens, G. Klyasova, D. Engelhard, W. Kern, C. Viscoli, M. Akova, O. Marchetti

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e25-e27
JournalClinical Microbiology and Infection
Volume21
Issue number3
DOIs
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Orasch, C., Averbuch, D., Mikulska, M., Cordonnier, C., Livermore, D. M., Gyssens, I. C., Klyasova, G., Engelhard, D., Kern, W., Viscoli, C., Akova, M., & Marchetti, O. (2015). Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical. Clinical Microbiology and Infection, 21(3), e25-e27. https://doi.org/10.1016/j.cmi.2014.10.014